An Escalating Dose Regimen of Pegylated Interferon and Ribavirin in HCV Cirrhotic Patients Referred for Liver Transplant

To lessen the severity of recurrent hepatitis C virus (HCV) postliver transplantation (post-LT) by treating HCV patients with cirrhosis, we assessed the safety and efficacy of an escalating dose pegylated interferon (PEG-IFN)/ribavirin protocol in pre-LT patients. Ninety patients were treated with 9...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Transplantation 2009-09, Vol.88 (5), p.729-735
Hauptverfasser:	MASSOUMI, Hatef, ELSIESY, Hussein, KHAITOVA, Viktoriya, PETERSON, Brent, NORKUS, Edward, GREWAL, Priya, LIU, Lawrence, CHANG, Charissa, BACH, Nancy, SCHIANO, Thomas D
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Age Aged Albumin Antibiotics. Antiinfectious agents. Antiparasitic agents Antiviral agents Antiviral Agents - therapeutic use Biological and medical sciences Cirrhosis Drug Administration Schedule Female Fundamental and applied biological sciences. Psychology Fundamental immunology Genotype Genotypes Hepacivirus - metabolism Hepatitis C - drug therapy Hepatitis C - virology Hepatitis C virus Humans Interferon Interferon-alpha - therapeutic use Liver Cirrhosis - drug therapy Liver Cirrhosis - therapy Liver Cirrhosis - virology Liver diseases Liver transplantation Liver Transplantation - methods Male Medical sciences Middle Aged Pharmacology. Drug treatments Polyethylene Glycols - therapeutic use Recombinant Proteins Ribavirin Ribavirin - therapeutic use Side effects Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Tissue, organ and graft immunology Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!